GlaxoSmithKline (GSK) Gets a Hold from Barclays
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
FierceBiotech2h
GSK gears up for depemokimab debut with twin FDA filings and phase 3 data dump
With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...
Hosted on MSN3h
Twice-Yearly Biologic Effective Against Nasal Polyps
Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials ...
Hosted on MSN3h
Tezspire Treats Chronic Sinus Symptoms With Nasal Polyps
Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...
The Whitehaven News3h
The end of an era for pharmaceutical giant
This summer is likely to be an emotional time for many in Ulverston.
Is GSK plc (GSK) the Best Weight Loss Drug Stock to Buy According to Analysts?
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Taiwan News9h
Europe Antibiotics Market Poised for Growth with a 2.8% CAGR to Surpass USD 14 Billion by 2030
The Europe Antibiotics Market is witnessing steady growth, driven by the increasing prevalence of infectious diseases, an aging population, and advancements in diagnostic capabilities. These factors ...
thewhistler.ng17h
Pharmacists Advocate FG Subsidy To Bring Down Rising Cost Of Vaccines, Essentials Drugs
Say Manufacturers Ready To Bridge Impact Of GSK, Others Exit From Nigeria Nigerian Pharmaceutical companies are beginning to ...